LADX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LADX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
LadRx's book value per share for the quarter that ended in Dec. 2023 was $0.22.
During the past 3 years, the average Book Value Per Share Growth Rate was -79.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of LadRx was 226.80% per year. The lowest was -79.30% per year. And the median was -18.70% per year.
LadRx's current price is $2.23. Its book value per share for the quarter that ended in Dec. 2023 was $0.22. Hence, today's PB Ratio of LadRx is 10.32.
During the past 13 years, the highest P/B Ratio of LadRx was 31.92. The lowest was 0.01. And the median was 1.72.
Warning Sign:
LadRx Corp stock PB Ratio (=9.81) is close to 10-year high of 9.81
The historical data trend for LadRx's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LadRx Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Book Value per Share | Get a 7-Day Free Trial | 45.20 | 24.32 | 1.94 | -2.93 | 0.22 |
LadRx Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Book Value per Share | Get a 7-Day Free Trial | -2.93 | -3.88 | 3.60 | 1.95 | 0.22 |
For the Biotechnology subindustry, LadRx's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, LadRx's PB Ratio distribution charts can be found below:
* The bar in red indicates where LadRx's PB Ratio falls into.
LadRx's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
Book Value Per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
= | (0.11 | - | 0.00) | / | 0.50 | |
= | 0.22 |
LadRx's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:
Book Value Per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
= | (0.11 | - | 0.00) | / | 0.50 | |
= | 0.22 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
LadRx (OTCPK:LADX) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Thank you for viewing the detailed overview of LadRx's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Cary J Claiborne | director | 3056 SENECA CHIEF TRAIL, ELLICOTT CITY MD 21042 |
Stephen Snowdy | officer: Chief Executive Officer | C/O CYTRX CORPORATION, 11726 SAN VICENTE BOULEVARD, SUITE 650, LOS ANGELES CA 90049 |
Jennifer K. Simpson | director | C/O DELCATH SYSTEMS, INC., 810 SEVENTH AVENUE, SUITE 3505, NEW YORK NY 10019 |
Eric Curtis | officer: Pres., Chief Operating Officer | ONE MAIN STREET, SUITE 800, CAMBRIDGE MA 02142 |
Felix Kratz | officer: Vice President Drug Discovery | 11726 SAN VICENTE BLVD., SUITE 650, LOS ANGELES CA 90049 |
Joel K Caldwell | director | 11726 SAN VICENTE BLVD., SUITE 650, LOS ANGELES CA 90049 |
Chawla Shanta M.d. | officer: Senior VP-Drug Development | 11726 SAN VICENTE BLVD., SUITE 650, LOS ANGELES CA 90049 |
Earl W Brien | director | 11726 SAN VICENTE BLVD, SUITE 650, LOS ANGELES CA 90049 |
Olivia C Ware | officer: Chief Commercial Officer | 11726 SAN VICENTE BLVD, SUITE 650, LOS ANGELES CA 90049 |
Cheryl Cohen | director | C/O MEDIVATION, INC., 201 SPEAR ST., 3RD FLOOR, SAN FRANCISCO CA 94105 |
Eric Jay Selter | director | 11726 SAN VICENTE BLVD., SUITE 650, LOS ANGELES CA 90049 |
Anita J Chawla | director | 11726 SAN VICENTE BLVD., SUITE 650, LOS ANGELES CA 90049 |
Joseph Rubinfeld | director | C/O SUPERGEN INC, 4140 DUBLIN BLVD STE 200, DUBLIN CA 94568 |
Douglas Scott Wieland | officer: Sr VP - Drug Development | 11726 SAN VICENTE BLVD., SUITE 650, LOS ANGELES CA 90049 |
Louis Ignarro | director | 11726 SAN VICENTE BLVD, STE 650, LOS ANGELES CA 90049 |
From GuruFocus
By PRNewswire PRNewswire • 05-02-2019
By PRNewswire PRNewswire • 04-29-2020
By PRNewswire PRNewswire • 02-13-2019
By PRNewswire PRNewswire • 11-08-2018
By PRNewswire PRNewswire • 05-08-2019
By PRNewswire PRNewswire • 04-29-2019
By PRNewswire PRNewswire • 10-29-2018
By PRNewswire PRNewswire • 08-01-2018
By PRNewswire PRNewswire • 01-29-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.